Tempus is helping transform drug discovery by breaking down information silos to link clinical, DNA, RNA, and whole slide pathology imaging data modalities together. With this structured data, we can power AI and machine learning approaches to accelerate drug development for patients.
with treatment and outcomes to power large real-world evidence studies
with comprehensive genomic profiling to understand driver mutations and outcomes associations
Tempus has built the world’s largest library of clinical and molecular data, is a leader in the field of personalized medicine, and like Genmab, Tempus has a mission to improve the lives of cancer patients. We are looking forward to expanding our exciting partnership with them and to the possibility of discovering important new oncology targets and biomarkers.
POWER YOUR INNOVATION AND DISCOVERY
Lens is a cloud-based Platform as a Service used by pharma, biotech, and academia to derive actionable insights from Tempus’ multi-modal data assets. Lens provides on-demand access to Tempus data through an optimized cloud environment with all the data, analysis tools and compute needed to get to the answers you need.
Lens empowers users to rapidly extract value and insights in minutes instead of months. Learn more.
Data licensing and subscriptions give you full access and data downloads to power your research initiatives. Data is updated regularly as we continually expand our database.
TEMPUS|Explore: Gain insight in weeks rather than months or years by working with Tempus experts through Explore. Using the entire database, Tempus researchers answer queries to accelerate target identification, biomarker validation, gene expression analysis, clinical trial patient determination, and much more.
Inquire about collaboration opportunities with Tempus AI and Machine Learning Experts to support your drug development programs. We’ve established machine learning partnerships with numerous biopharmaceutical
companies focused on areas such as:
With Tempus’ data and the Lens Platform, collaborators are launching pragmatic AI applications, accelerating the pace of development and commercialization.
Explore Tempus data insights to identify disease biomarkers and develop targeted drugs and clinical trials for specific patient types.Lens offers multiple use cases to support drug development: